Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Multiple Dose PF-06651600 on Midazolam and Efavirenz PK
NCT03762928Phase 1Completed
- Sponsor
- Pfizer
- Start
- Dec 2018
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ritlecitinib tosilate in alopecia areata (2 arms), sponsored by Pfizer. Primary endpoints: Area under the curve at last quantifiable infinity time and Area under the Curve from time 0 to 72 hours. Started Dec 2018; status: completed.
02
Drugs
ritlecitinib tosilate
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT03762928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03762928.